https://www.selleckchem.com/pr....oducts/6-aminonicoti
In 2016, the Society of Surgical Oncology released a Choosing Wisely guideline recommending sentinel lymph node biopsy (SLN omission in females ≥70years of age with early-stage, hormone-positive, clinically node-negative invasive breast cancer. This study investigated the impact of this guideline on SLNB and radiotherapy rates, in addition to assessing temporal trends of nodal biopsy and factors associated with recurrence. The study involved a retrospective review of women who met the guideline criteria and underwent parti
Curtir
Comentario
Compartilhar
